FDA To Investigate Bone Drugs' Effects On Heart

Law360, New York (October 2, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration said on Monday that it is investigating the possible risk of developing an irregular heart rhythm when taking a class of drugs known as bisphosphonates, which are used to treat bone diseases.

The FDA said in a public statement that is investigating whether the drugs, used to treat osteoporosis and to encourage bone regrowth in cancer patients, cause a type of cardiac arrhythmia known as atrial fibrillation. The condition is not fatal by itself but may cause discomfort and increase...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.